- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Nuuvera Shortlisted for Cannabis Contract with the German Federal Institute for Drugs and Medical Devices
Nuuvera (TSXV:NUU) has announced that it has been shortlisted by the German Federal Institute for Drugs and Medical Devices for a contract to grow, process, store and delivery up to 600 kg of cannabis in Germany. As quoted in the press release: Over 100 interested undertakings answered BfArM’s initial call for competition. Nuuvera is one …
Nuuvera (TSXV:NUU) has announced that it has been shortlisted by the German Federal Institute for Drugs and Medical Devices for a contract to grow, process, store and delivery up to 600 kg of cannabis in Germany.
As quoted in the press release:
Over 100 interested undertakings answered BfArM’s initial call for competition. Nuuvera is one of 10 remaining bidders asked to submit an offer in the public procurement procedure.Lorne Abony, CEO of Nuuvera Inc. stated, “We are tremendously excited about BfArM’s decision, and for the headway Nuuvera has made in Germany, which is one of the largest markets in the world to legalize cannabis for medical usage.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.